liposom
versatil
sub
microns
membran
vesicl
use
varieti
applic
includ
drug
deliveri
vivo
imag
also
repres
excel
model
artifici
membran
cell
sever
studi
demonstr
vitro
transcript
translat
take
place
insid
liposom
obtain
compartment
product
function
protein
within
liposom
kita
et
al
chembiochem
minim
artifici
cellbas
model
ideal
synthet
biolog
base
applic
studi
propos
use
liposom
artifici
microb
vaccin
artifici
microb
genet
program
produc
specif
antigen
show
proofofconcept
artifici
cellbas
platform
bacteri
vitro
transcript
translat
system
togeth
gene
construct
encod
model
antigen
bgalactosidas
entrap
insid
multilamellar
liposom
vaccin
studi
mice
show
antigenexpress
immunostimulatori
liposom
anexil
elicit
higher
specif
humor
immun
respons
produc
antigen
bgalactosidas
control
vaccin
ie
anexil
without
genet
input
liposom
bgalactosidas
pdna
encod
bgalactosidas
conclus
anexil
present
new
platform
dnabas
vaccin
combin
antigen
product
adjuvant
deliveri
one
system
offer
sever
advantag
exist
vaccin
formul
synthet
biolog
rapidli
emerg
interdisciplinari
research
field
aim
construct
new
biolog
part
system
new
function
process
engin
standard
vaccin
may
also
benefit
synthet
biologybas
design
vaccin
aim
delud
immun
system
antigen
formul
make
believ
deal
natur
infect
howev
without
caus
ill
present
major
vaccin
market
consist
attenu
inactiv
pathogen
although
effect
system
poorli
defin
suffer
batchtobatch
variat
use
pathogen
readili
cultiv
lab
scale
permit
vaccin
product
moreov
ratio
antigen
compound
within
pathogen
moreorless
fix
poor
control
direct
antigen
compound
immun
reaction
evok
bottomup
design
vaccin
consist
welldefin
antigen
compound
eg
protein
nucleic
acid
offer
better
control
evok
immun
reaction
howev
design
vaccin
often
empir
gener
yield
vaccin
poorli
immunogen
reli
adjuv
order
effect
moreov
vaccin
product
scheme
rather
timeconsum
therefor
suitabl
rapid
respons
intervent
exampl
prevent
pandem
spread
new
influenza
strain
human
popul
cellfre
synthet
biolog
may
offer
new
way
design
potent
genet
programm
vaccin
jewett
et
al
tsuboi
et
al
tsuboi
et
al
zichel
et
al
kanter
et
al
simpson
base
vitro
transcript
translat
singl
multipl
gene
construct
order
obtain
function
part
system
applic
cellfre
biolog
includ
product
membran
protein
difficult
express
heterolog
host
henderson
et
al
jung
et
al
beeb
et
al
nozawa
et
al
reckel
et
al
ishihara
et
al
berrier
et
al
highthroughput
screen
protein
librari
vitro
compartment
mastrobattista
et
al
gener
artifici
cell
encapsul
complex
biochem
reaction
cellsiz
compart
like
liposom
kita
et
al
sunami
et
al
sunami
et
al
yamaji
et
al
murta
et
al
ishikawa
et
al
oberholz
et
al
recent
shown
protein
express
liposom
yield
microgramquant
model
antigen
amidi
et
al
studi
propos
use
antigenexpress
immunostimulatori
liposom
anexil
artifici
microb
vaccin
fig
potenti
advantag
antigenexpress
immunostimulatori
liposom
anexil
convent
vaccin
numer
specif
vaccin
easili
alter
simpli
chang
dna
templat
without
chang
entir
vaccin
formul
moreov
compar
dna
vaccin
anexil
exclus
reli
often
ineffici
transfect
dna
cell
vaccin
recipi
order
effect
secondli
compar
vectorbas
vaccin
anexil
unaffect
neutral
antibodi
vector
thirdli
limit
number
gene
express
insid
anexil
lastli
anexil
mimic
characterist
virus
bacteria
without
safeti
concern
relat
use
attenu
pathogen
vaccin
show
anexil
express
bgalactosidas
well
toler
im
inject
capabl
induc
strong
system
immun
respons
superior
liposom
dna
protein
vaccin
encod
antigen
eggderiv
laphosphatidylcholin
epc
glycol
peg
dspepeg
n
iminodiacet
acid
succinyl
dogsnta
purchas
avanti
polar
lipid
inc
alabast
alabama
usa
luria
broth
triphosph
atp
phosphoenolpyruv
pep
triphosph
ctp
triphosph
gtp
cyclic
adenosin
monophosph
camp
folin
acid
cholesterol
chol
bgalactosidas
enzym
iumg
encod
amino
acid
purchas
sigma
saint
loui
mo
usa
fluorescein
dibdgalactopyranosid
fdg
suppli
marker
gene
technolog
eugen
usa
ecoli
trna
creatin
kinas
creatin
phosphat
obtain
roch
basel
switzerland
uridin
triphosph
utp
polymeras
suppli
fermenta
burlington
ontario
canada
dithiothreitol
dtt
lysogeni
broth
lb
pyruv
kinas
pk
flucka
seelz
germani
rabbit
polyclon
antibgalactosidas
igg
conjug
goat
igg
antirabbit
immunoglobulin
abcam
cambridg
uk
horseradish
peroxidas
hrp
label
goat
antimous
total
igg
hrplabel
rabbit
antimous
purchas
invitrogen
breda
netherland
hrplabel
rat
monoclon
antimous
obtain
abcam
cambridg
unit
kingdom
peg
promega
madison
wi
usa
materi
use
analyt
pharmaceut
grade
prepar
pegliposom
ni
nta
liposom
mixtur
lmol
total
lipid
epc
chol
dspepeg
molar
ratio
epc
chol
peg
fig
schemat
represent
anexil
formul
use
studi
epc
chol
dogsnta
molar
ratio
epc
chol
dogsnta
dissolv
dichloromethan
diethyleth
vv
round
bottom
flask
thin
dri
lipid
film
obtain
evapor
solvent
use
rotari
evapor
vacuum
subsequ
dri
nitrogen
min
lipid
film
hydrat
distil
water
shake
use
glass
bead
form
larg
multilamellar
liposom
sonic
probe
sonic
produc
unilamellar
liposom
liposom
suspens
divid
aliquot
ml
tube
lm
total
lipidsbatch
freezedri
obtain
lyophil
lipid
cake
store
desicc
room
temperatur
use
volumeweight
mean
diamet
size
distribut
liposom
determin
singl
particl
optic
sens
accus
tm
santa
barbara
california
usa
cellfre
protein
express
e
coli
bgalactosidas
use
model
antigen
lacz
encod
e
coli
bgalactosidas
clone
vector
allow
promoterdriven
express
prokaryot
cellfre
transcript
translat
system
vector
append
code
sequenc
ctermin
end
lacz
effici
purif
bgalactosidas
protein
amidi
et
al
ecoli
tuner
tm
strain
devoid
endogen
bgalactosidas
merck
chemic
ltd
nottingham
uk
use
make
bacteri
extract
describ
previous
amidi
et
al
coupl
vitro
transcript
translat
reaction
mixtur
refer
ivtt
mix
consist
vv
extract
lgml
trna
lgml
creatin
kinas
mm
magnesium
acet
polymeras
vv
lowmolecularweight
mix
lm
mix
contain
mm
hepe
mm
dtt
mm
atp
mm
ctp
mm
gtp
mm
utp
creatin
phosphat
cp
mm
camp
mm
folin
acid
potassium
acet
mm
ammonium
acet
mm
amino
acid
vv
use
protein
synthesi
initi
protein
express
plasmid
dna
ad
ivtt
mix
final
concentr
nm
reaction
mixtur
incub
h
gener
bgalactosidaseproduc
anexil
prepar
anexil
bgalactosidas
express
insid
liposom
refer
anexilin
ivtt
mixtur
final
concentr
nm
use
rehydr
batch
lm
peglipid
cake
order
form
liposom
encapsul
ivtt
mix
pdna
liposom
incub
ice
min
complet
rehydr
process
inactiv
protein
express
outsid
liposom
rnase
final
concentr
lgml
ad
liposom
suspens
sampl
incub
h
allow
protein
synthesi
complet
prepar
bgalactosidasebound
onto
ni
nta
liposom
refer
anexilon
bgalactosidas
express
bulk
subsequ
bound
onto
liposom
bilay
describ
ninetyl
ivtt
pdna
templat
final
concentr
nm
use
bulk
express
bgalactosidas
ctermin
ivtt
mix
dna
templat
incub
h
express
complet
reaction
mix
contain
express
bgalactosidas
ad
ntalipid
cake
lm
lipid
incub
min
room
temperatur
form
liposom
express
bgalactosidas
residu
bind
ni
ion
ni
nta
liposom
remov
non
attach
bgalactosidas
liposom
wash
three
time
ml
phosphat
buffer
salin
pb
nacl
concentr
adjust
make
isoton
ivtt
mix
centrifug
min
wash
liposom
resuspend
pb
aqueou
solut
bgalactosidas
protein
iuml
prepar
pb
subsequ
solut
slowli
ad
freezedri
lipid
lm
incub
min
room
temperatur
rehydr
complet
liposom
form
remov
nonencapsul
bgalactosidas
liposom
wash
three
time
pb
centrifug
min
resuspend
pb
amount
encapsul
bgalactosidas
pegliposom
calcul
total
amount
protein
entrap
antigenexpress
immunostimulatori
liposom
genet
programm
synthet
vaccin
liposom
formul
pdna
encod
bgalactosidas
coentrap
bgalactosidas
enzym
concentr
nm
amount
encapsul
bgalactosidas
measur
base
enzymat
activ
quantif
antigen
produc
bgalactosidas
bgalactosidas
activ
assay
amount
encapsul
bgalactosidas
well
express
bgalactosidas
bulk
insid
pegliposom
bound
onto
ni
nta
liposom
determin
base
enzymat
activ
bgalactosidas
use
fluoresc
spectroscopi
amidi
et
al
briefli
assay
fdg
substrat
cleav
bgalactosidas
fluorescein
two
galactos
molecul
twostep
reaction
use
high
fdg
concentr
rel
enzym
concentr
concentr
form
bgalactosidas
could
directli
deduc
substrat
convers
rate
measur
increas
fluorescein
fluoresc
time
excitationemiss
wavelength
nm
calibr
curv
lgml
correspond
iuml
commerci
avail
purifi
e
coli
bgalactosidas
use
experi
determin
amount
encapsul
bgalactosidas
form
ivtt
liposom
liposom
suspens
dilut
cell
lytic
b
buffer
sigma
saint
loui
mo
usa
disrupt
liposom
releas
produc
protein
treatment
done
blank
liposom
formul
standard
correct
possibl
interfer
lipid
compon
cell
lytic
b
buffer
gener
fluoresc
signal
subsequ
substrat
fdg
mm
automat
ad
sampl
standard
gener
fluoresc
signal
measur
everi
period
use
fluoresc
wellplat
reader
fluostar
optima
bmglabtech
offenburg
germani
determin
concentr
encapsul
express
bgalactosidas
initi
substrat
convers
slope
rel
light
unit
rlu
determin
compar
standard
known
concentr
bgalactosidas
amidi
et
al
western
blot
done
evalu
antigen
express
bgalactosidas
liposom
contain
bgalactosidas
disrupt
ad
cell
lytic
b
buffer
liposom
suspens
ad
electrophoresi
loadingbuff
mm
trishcl
ph
glycerol
sd
contain
bromophenol
blue
solut
bmercaptoethanol
sampl
heat
min
electrophores
v
reduc
condit
sdspolyacrylamid
gel
bollag
edelstein
gel
electrophoresi
antigen
band
transfer
nitrocellulos
membran
use
dri
western
blot
system
iblot
invitrogen
frederick
md
min
blot
free
site
block
nonfat
milkpowd
pb
contain
tween
pbst
next
membran
incub
solut
goat
antibgalactosidas
polyclon
antibodi
pbst
contain
nonfat
milk
powder
membran
wash
remov
unbound
antibodi
incub
rabbit
igg
antigoat
immunoglobulin
blot
antigenantibodi
complex
visual
fluoresc
use
typhoon
imag
amersham
corpor
arlington
heigth
il
usa
femal
balbc
mice
week
old
charl
river
netherland
hous
group
maintain
anim
facil
utrecht
univers
h
day
night
schedul
food
water
ad
libitum
experi
approv
ethic
committe
anim
experiment
utrecht
univers
mice
per
group
intramuscularli
im
immun
twice
interv
mice
receiv
differ
formul
tabl
divid
two
batch
inject
hind
leg
muscl
immun
week
last
immun
mice
bled
cheek
punctur
sacrif
inhal
excess
co
individu
serum
sampl
separ
blood
cell
coagul
protein
centrifug
min
store
bgalactosidasespecif
antibodi
respons
determin
use
enzymelink
immunosorb
assay
elisa
briefli
elisa
plate
high
bind
capac
greiner
alphen
ad
rijn
netherland
coat
overnight
ambient
temperatur
bgalactosidas
ng
llwell
coat
buffer
carbonatebicarbon
ph
measur
antibodi
respons
mice
vaccin
liposom
contain
express
bgalactosidas
elisa
plate
coat
recombinantli
produc
bgalactosidas
e
coli
strain
invitrogen
carlsbad
ca
purifi
use
akta
purifi
equip
ml
histrap
hp
column
ge
healthcar
uppsala
sweden
serum
sampl
mice
vaccin
control
formul
contain
bgalactosidas
encapsul
liposom
plate
coat
commerci
sourc
bgalactosidas
use
entrap
coat
plate
wash
block
incub
wv
milk
powder
coat
buffer
llwell
h
subsequ
plate
wash
pb
contain
tween
ph
pbstween
appropri
dilut
sera
individu
mous
appli
plate
serial
dilut
twofold
pb
tween
incub
h
plate
wash
incub
either
horseradish
peroxidas
hrp
conjug
goat
antibodi
mice
igg
hrpconjug
rabbit
antibodi
mice
hrpconjug
rat
antibodi
mice
dilut
pbstween
llwell
h
thereaft
plate
wash
twice
pbstween
pb
specif
antibodi
detect
ad
tetra
methyl
benzidin
tmb
mgml
mm
sodium
acet
ph
buffer
also
contain
vv
hydrogen
peroxid
well
min
reaction
stop
ad
h
well
total
igg
antibodi
titer
express
reciproc
sampl
dilut
correspond
background
amidi
et
al
comparison
mice
differ
group
posit
titer
made
oneway
anova
test
character
anexil
liposom
load
bgalactosidas
andor
pdna
cellfre
protein
synthesi
use
transcrib
translat
lacz
gene
encod
e
coli
bgalactosidas
either
bulk
insid
liposom
compart
anexilsin
adher
onto
surfac
liposom
anexilon
detail
liposom
prepar
see
materi
method
section
volumeweight
mean
diamet
bgalactosidaseload
liposom
anexil
formul
approxim
lm
dose
bgalactosidas
standard
mu
per
formul
see
materi
method
correspond
approxim
lg
activ
bgalactosidas
commerci
sourc
sigma
extract
use
ivtt
deriv
e
coli
tuner
tm
strain
devoid
endogen
bgalactosidas
import
avoid
interfer
endogen
bgalactosidas
experi
amidi
et
al
sdspage
western
blot
analysi
extract
made
ecoli
tuner
tm
strain
prove
absenc
endogen
bgalactosidas
extract
fig
importantli
western
blot
analysi
confirm
express
bgalactosidas
recogn
polyval
antibgalactosidas
antibodi
antigen
bgalactosidas
preserv
ivtt
mix
fig
system
antibodi
respons
im
immun
mice
investig
potenc
anexil
altern
convent
protein
dna
vaccin
compar
system
humor
respons
mice
immun
im
anexilin
anexilon
pcmvlacz
encapsul
liposom
refer
liposom
dna
vaccin
bgalactosidas
encapsul
liposom
refer
liposom
protein
vaccin
bgalactosidas
coencapsul
pdna
pivexlacz
liposom
refer
liposom
proteindna
vaccin
liposom
dna
vaccin
poorli
immunogen
induc
low
serum
igg
titer
vaccin
anim
singl
dose
im
immun
fig
contrast
anexilin
induc
high
serum
antibodi
respons
im
immun
significantli
higher
achiev
im
inject
liposom
protein
liposom
proteindna
vaccin
fig
p
singl
im
vaccin
anexilon
could
elicit
substanti
higher
serum
antibodi
respons
elicit
vaccin
fig
b
p
shown
surfacelink
liposom
antigen
could
enhanc
present
antigen
apc
induc
stronger
immun
respons
taneichi
et
al
naito
et
al
uchida
taneichi
altogeth
result
point
strong
immunostimul
effect
anexil
vaccin
robust
impact
surfac
antigen
present
system
antibodi
respons
sinc
usual
need
booster
vaccin
order
induc
prolong
strong
immun
respons
effect
booster
immun
system
antibodi
product
studi
mice
booster
immun
group
mice
show
higher
igg
titer
significantli
higher
prime
immun
fig
exclud
observ
antibgalactosidas
serum
titer
induc
compon
within
bacteri
extract
serum
antibodi
titer
mice
inject
anexil
without
pdna
encod
bgalactosidas
measur
im
immun
pdnalack
anexil
mice
show
neglig
bgalactosidas
specif
antibodi
respons
fig
clearli
indic
antigen
specif
immun
respons
exclus
mediat
genet
input
gain
insight
natur
qualiti
system
immun
respons
subclass
bgalactosidasespecif
antibodi
fig
b
determin
im
immun
liposom
dna
vaccin
detect
level
sera
vaccin
mice
compar
liposom
protein
proteindna
vaccin
anexilin
anexilon
vaccin
show
superior
p
p
respons
induc
anexilon
highest
fig
b
respons
control
test
formul
larg
correspond
total
igg
respons
fig
b
remark
anexilon
induc
significantli
higher
antibodi
level
fig
consequ
notabl
higher
ratio
booster
vaccin
compar
formul
fig
sera
collect
day
immun
antibodi
titer
express
mean
respond
mice
bar
repres
confid
interv
number
column
indic
number
respond
per
group
asterisk
indic
titer
significantli
p
p
higher
group
immun
booster
vaccin
liposom
proteindna
vaccin
circl
indic
titer
significantli
higher
group
immun
booster
vaccin
anexilin
result
present
demonstr
anexil
use
synthet
biolog
platform
construct
vaccin
genet
program
order
obtain
antigenspecif
anexil
mimic
characterist
natur
pathogen
without
virul
abl
induc
strong
humor
immun
respons
particl
size
anexil
amen
uptak
antigen
present
cell
foge
et
al
tabata
et
al
xiang
et
al
yoshida
babense
amount
encapsul
liposom
nm
suffici
initi
vitro
protein
express
liposom
compart
bgalactosidas
success
produc
quantifi
liposom
enzymat
activ
use
fast
sensit
method
evalu
biolog
activ
quantif
express
bgalactosidas
anexil
show
produc
enzym
correct
fold
activ
cellfre
protein
synthesi
western
blot
analysi
show
antigen
express
bgalactosidas
preserv
result
indic
cellfre
protein
synthesi
effici
produc
antigen
avoid
complex
mainten
cell
viabil
associ
recombin
vivo
system
jewett
et
al
furthermor
demonstr
use
anexil
circumv
current
problem
low
immunogen
nonadjuv
dna
vaccin
liu
ulmer
rosenberg
et
al
trimbl
et
al
oppos
im
vaccin
liposom
dna
vaccin
im
immun
anexil
result
strong
humor
immun
respons
result
agreement
studi
show
dna
vaccin
incap
induc
strong
antibodi
respons
probabl
poor
transfect
dna
endogen
cell
lead
low
dose
antigen
produc
abdulhaqq
weiner
lu
moreov
anexil
abl
induc
significantli
higher
antibodi
respons
compar
convent
liposom
encapsul
antigen
without
pdna
result
demonstr
strong
immunostimul
effect
anexil
altern
dna
protein
vaccin
factor
might
contribut
adjuv
effect
anexil
includ
effici
deliveri
antigen
apc
possibl
adjuv
activ
pdna
due
cpg
methyl
pattern
klinman
et
al
presenc
pathogenassoci
molecular
pattern
pamp
bacteri
extract
activ
innat
immun
system
via
pattern
recognit
receptor
anexilon
surfacedlink
bgalactosidas
test
mice
altern
anexilin
formul
antigen
entrap
insid
vesicl
result
vaccin
studi
anexilon
conclud
antigen
present
surfac
liposom
could
significantli
enhanc
system
immun
respons
compar
test
formul
even
singl
immun
suffici
strongli
stimul
immun
respons
superior
achiev
im
immun
convent
liposom
vaccin
sever
studi
previous
shown
surfacelink
liposom
antigen
could
enhanc
present
antigen
apc
induc
stronger
immun
respons
matsui
et
al
ohno
et
al
takagi
et
al
taneichi
et
al
impact
anexil
control
vaccin
antibodi
subtyp
profil
also
investig
infecti
diseas
protect
viral
bacteri
infect
mainli
mediat
neutral
immunoglobulin
bind
viral
bacteri
antigen
gissmann
ho
et
al
montefiori
et
al
montefiori
mascola
sattentau
smith
mice
antibodi
known
contribut
viru
neutral
report
contribut
complement
activ
antibodydepend
cellmedi
immun
effect
protect
viral
infect
prevent
viru
replic
couteli
et
al
hocart
et
al
hand
absolut
concentr
igg
import
reduc
viral
shed
hocart
et
al
hovden
et
al
therefor
induct
combin
thelper
thelper
respons
may
improv
vaccin
efficaci
especi
viral
infect
studi
im
immun
vaccin
result
mix
th
th
immun
respons
im
administ
anexil
abl
markedli
enhanc
respons
im
vaccin
compar
protein
dna
liposom
formul
fig
b
may
advantag
protect
viral
intracellular
bacteri
infect
ratio
anexilin
highest
among
vaccin
prime
vaccin
fig
anexilon
substanti
increas
booster
immun
fig
data
suggest
qualiti
immun
respons
bgalactosidas
vaccin
substanti
affect
characterist
anexil
formul
work
present
show
first
time
liposom
use
antigenproduc
artificialcel
vaccin
anexil
combin
antigenproduct
deliveri
adjuvant
one
system
make
potent
induc
antibodi
respons
compar
liposom
dna
vaccin
shown
still
specif
anexil
determin
genet
input
offer
great
flexibl
vaccin
product
formul
preliminari
data
lab
show
possibl
store
anexil
lyophil
upon
hydrat
dna
solut
dna
transcrib
translat
insid
rehydr
liposom
data
shown
univers
vaccin
platform
may
solv
problem
product
lagtim
convent
vaccin
hinman
et
al
desroch
et
al
ulmer
et
al
furthermor
may
allow
easi
product
person
vaccin
eg
cancer
vaccin
antigen
optim
individu
poland
et
al
although
test
inject
bacteri
compon
essenti
part
anexil
formul
may
pose
problem
reactogen
extract
deriv
e
coli
essenti
compon
anexil
like
contain
pyrogen
endotoxin
lp
visual
inspect
mice
im
administr
anexil
show
discomfort
ill
nevertheless
altern
sourc
ivtt
mix
free
endotoxin
test
exampl
extract
prepar
gramposit
bacteria
wheat
germ
synthet
purexpress
system
shimizu
et
al
may
substitut
e
colibas
extract
although
use
singl
antigen
show
proofofconcept
anexil
vaccin
platform
mixtur
antigen
express
insid
anexil
simpli
mix
pdna
encod
differ
antigen
although
differ
antigen
differ
level
express
cellfre
express
system
gener
express
level
high
enough
purpos
vaccin
microgram
quantiti
protein
requir
fact
membran
protein
often
difficult
produc
bacteria
show
remark
high
level
express
prokaryot
cellfre
system
presenc
liposom
jung
et
al
goren
et
al
kuruma
et
al
moritani
et
al
nozawa
et
al
reckel
et
al
besid
dna
encod
antigen
varieti
genet
input
use
order
control
type
immun
respons
provok
exampl
genet
adjuv
chemokin
cytokin
may
coexpress
insid
anexil
order
enhanc
influx
immun
cell
site
inject
uptak
anexil
antigen
present
cell
anexil
form
excel
synthet
biolog
platform
genet
program
use
standard
biolog
part
canton
et
al
knight
conclus
shown
proofofconcept
genet
programm
vaccin
base
situ
product
antigen
dna
templat
immun
studi
focus
coadminist
dna
encod
biolog
relev
antigen
genet
adjuv
eg
cytokin
need
demonstr
possibl
limit
anexil
vaccin
platform
author
declar
conflict
interest
open
access
articl
distribut
term
creativ
common
attribut
noncommerci
licens
permit
noncommerci
use
distribut
reproduct
medium
provid
origin
author
sourc
credit
